Phase 3 trial (air-CF 1) measuring improvement in respiratory symptoms in patients with cystic fibrosis (CF) following treatment with aztreonam lysine for inhalation (AZLI)

被引：0
|
作者：
Retsch-Bogart, G. Z. [1 ]
Montgomery, B. [2 ]
Gibson, R. [3 ]
McCoy, K. [4 ]
Oermann, C. M. [5 ]
Cooper, P. [6 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Gilead Sci Inc, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Ohio State Univ, Columbus, OH 43210 USA
[5] Baylor Coll Med, Houston, TX 77030 USA
[6] Childrens Hosp, Westmead, NSW, Australia
来源：
PEDIATRIC PULMONOLOGY | 2007年
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
308
引用
收藏
页码：310 / 311
页数：2
相关论文
共 17 条
  • [1] AZTREONAM FOR INHALATION SOLUTION (AZLI) TREATMENT IN CHILDREN WITH CYSTIC FIBROSIS (CF) AND CHRONIC PSEUDOMONAS AERUGINOSA (PA) INFECTION
    Accurso, F. J.
    Fayon, M.
    Sermet, I.
    Lewis, S.
    Bresnik, M.
    Oermann, C. M.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 343 - 343
  • [2] Effect of 28-Day Aztreonam for Inhalation Solution (AZLI) Therapy on Cystic Fibrosis (CF) Respiratory Pathogens.
    Braff, M.
    Retsch-Bogart, G.
    McCoy, K.
    Lewis, S.
    Henig, N. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [3] THE EFFECT OF BURKHOLDERIA COLONY MORPHOLOGY IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES IN A RANDOMIZED TRIAL OF AZTREONAM FOR INHALATION SOLUTION (AZLI)
    Burns, J. L.
    LiPuma, J.
    McKevitt, M.
    Lewis, S.
    Retsch-Bogart, G. Z.
    Bresnik, M.
    Henig, N. R.
    Tullis, E.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 333 - 333
  • [4] AZTEC-CF STUDY: AZTREONAM LYSINE FOR INHALATION IN THE TREATMENT OF PULMONARY EXACERBATIONS OF CYSTIC FIBROSIS
    Frost, F.
    Nazareth, D.
    Walshaw, M.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 330 - 330
  • [5] Hospitalization Risk of Current Standard of Care (SOC) vs Aztreonam for Inhalation Solution (AZLI) in Patients with Cystic Fibrosis (CF)
    Montgomery, A. B.
    Lewis, S.
    Higuchi, K.
    Marshall, B.
    Oermann, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [6] LUNG FUNCTION IMPROVEMENT WITH AZTREONAM FOR INHALATION SOLUTION (AZLI) IN THE SINGLE-ARM EXTENSION OF A RANDOMIZED TRIAL OF INHALED ANTIPSEUDOMONAL ANTIBIOTICS IN PATIENTS WITH CYSTIC FIBROSIS (CF) AND PSEUDOMONAS AERUGINOSA INFECTION
    Assael, B. M.
    Chiron, R.
    Fischer, R.
    Bresnik, M.
    Lewis, S.
    Pressler, T.
    Oermann, C. M.
    PEDIATRIC PULMONOLOGY, 2011, : 312 - 312
  • [7] LUNG FUNCTION IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA (BURK) SPECIES INFECTION OVER THE COURSE OF A PROSPECTIVE, RANDOMIZED TRIAL OF AZTREONAM FOR INHALATION SOLUTION (AZLI)
    Tullis, E.
    Burns, J. L.
    Retsch-Bogart, G. Z.
    Bresnik, M.
    Lewis, S.
    LiPuma, J.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 334 - 334
  • [8] EFFECTS OF CONTINUOUS AZTREONAM FOR INHALATION SOLUTION (AZLI) USE ON PATHOGENS AND ANTIBIOTIC SUSCEPTIBILITY IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES INFECTION
    Tullis, E.
    LiPuma, J. J.
    Retsch-Bogart, G.
    Bresnik, M.
    Henig, N.
    McKevitt, M.
    Lewis, S.
    Burns, J. L.
    PEDIATRIC PULMONOLOGY, 2011, : 305 - 305
  • [9] AZTREONAM FOR INHALATION SOLUTION (AZLI) IN CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC BURKHOLDERIA SPECIES (BURK) INFECTION: INITIAL RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Tullis, E.
    Burns, J. L.
    Retsch-Bogart, G.
    Bresnik, M.
    Henig, N. R.
    Lewis, S.
    LiPuma, J. J.
    PEDIATRIC PULMONOLOGY, 2011, : 296 - 296
  • [10] Two phase 3 placebo-controlled trials of aztreonam lysine for inhalation (AZLI) for non-cystic fibrosis bronchiectasis (NCFB)
    Barker, Alan
    O'Donnell, Anne
    Thompson, Philip J.
    Flume, Patrick
    Ruzi, Jonathan
    de Gracia, Javier
    Boersma, Wim
    Polverino, Eva
    Shao, Lixin
    Zhang, Jenny
    Leitzinger, Sheila
    Haas, Laura
    McKevitt, Matt
    Montgomery, A. Bruce
    Quittner, Alexandra
    Gossage, David
    O'Riordan, Thomas
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12